Cell and Gene Therapy

The latest market intelligence, insights and interviews covering the cell and gene therapy industry's most pressing challenges, from translation to automation, manufacturing to market access, viral vectors to bioreactors.

 

Cell and Gene Therapy
03/02/2020

 From patent infringements, a flurry of M&As, CRISPR trials in humans; Phacilitate's annual top ten list was revealed at Phacilitate...